BN BROOKFIELD Corp /ON/ IFRS
Opeators of Nonresidential Buildings · NYSE · SEC CIK 1001085 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $75.10B | $86.01B | $95.92B | $92.77B | $75.73B |
| Cost of revenue | $28.35B | $40.12B | $52.22B | $54.04B | $44.15B |
| SG&A expense | $5.13B | $4.93B | $5.35B | $3.93B | $3.20B |
| Interest expense | — | — | — | $10.70B | $7.60B |
| Income tax | $1.14B | $982.00M | $1.01B | $1.47B | $2.32B |
| Net income | $1.31B | $641.00M | $1.13B | $2.06B | $3.97B |
| EPS (basic) | 0.51 | 0.21 | 0.62 | 1.22 | 2.47 |
| EPS (diluted) | 0.49 | 0.20 | 0.61 | 1.19 | 2.39 |
| Weighted avg. shares (diluted) | 2.37B | 2.38B | 1.59B | 1.61B | 1.59B |
| Balance sheet | |||||
| Cash & equivalents | $16.24B | $15.05B | $11.22B | $14.40B | $12.69B |
| Receivables | $22.77B | $20.28B | $20.26B | $19.49B | $16.10B |
| Inventory | $5.92B | $5.42B | $7.06B | $9.11B | $8.56B |
| PP&E, netmay include right-of-use assets (IFRS) | $165.99B | $153.02B | $147.62B | $124.27B | $115.49B |
| Goodwill | $43.35B | $35.73B | $34.91B | $28.66B | $20.23B |
| Intangibles | $38.50B | $36.07B | $38.99B | $38.41B | $30.61B |
| Total assets | $518.97B | $490.42B | $490.10B | $441.28B | $391.00B |
| Short-term debt | — | $767.00M | $608.00M | $0 | $912.00M |
| Long-term debt | $13.80B | $13.46B | $11.55B | $11.39B | $9.96B |
| Total debt | $13.80B | $14.23B | $12.16B | $11.39B | $10.88B |
| Total liabilities | $352.78B | $325.04B | $321.85B | $299.39B | $256.26B |
| Shareholders' equity | $166.19B | $165.38B | $168.24B | $141.89B | $134.74B |
| Net debt | -$2.44B | -$819.00M | $938.00M | -$3.01B | -$1.82B |
| Cash flow statement | |||||
| Operating cash flow | $10.96B | $7.57B | $6.47B | $8.75B | $7.87B |
| Capital expenditure | $14.75B | $11.17B | $8.07B | $7.24B | $6.88B |
| Free cash flow | -$3.79B | -$3.60B | -$1.60B | $1.51B | $993.00M |
| Investing cash flow | -$31.78B | -$29.96B | -$29.76B | -$39.65B | -$21.05B |
| Financing cash flow | $21.69B | $26.90B | $19.93B | $32.46B | $16.26B |
| Depreciation & amortization | $10.38B | $9.74B | $9.07B | $7.68B | $6.44B |
| Stock-based compensation | $123.00M | $106.00M | $105.00M | $167.00M | $121.00M |
| Dividends paid | $552.00M | $495.00M | $436.00M | $879.00M | $1.34B |
Free plan shows the latest 5 periods; Pro shows all 10 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.